ChordNews
← All news

Tactile Medical sets 2026 adjusted EBITDA target of $50M-$52M and keeps revenue outlook at $360M-$366M

By ChordNews · First written (updated )

Comments 0

Summary

Tactile Medical is targeting $50 million to $52 million in adjusted EBITDA for 2026 while maintaining its revenue outlook of $360 million to $366 million. The summary is based on a breaking news headline only, as the article's body was not available.

This continues an earlier story: Orthopediatrics outlines $270M-$273M 2026 revenue outlook and targets $25M adjusted EBITDA

Later: Titan America updates 2026 outlook to mid-single-digit revenue growth and 250-300 bps EBITDA margin decline · ICU Medical signals 2026 results toward the high end of its EBITDA and EPS ranges · Starling Oncology expects 2026 revenue of $650M-$660M and adjusted EBITDA of $4M-$6M

Timeline

  1. Seeking Alpha

    Source ↗

    Seeking Alpha reports that Tactile Medical targets $50M-$52M adjusted EBITDA in 2026 while maintaining its $360M-$366M revenue outlook.

Comments

No comments yet.

    to like and comment.

    © 2026 ChordNews